Table 2.
Red Blood Cell Membrane PUFAs (% rel) |
Total Pre (n = 38) |
Total Post (n = 38) |
p | N-FZ Pre (n = 20) |
N-FZ Post (n = 20) |
p | H-FZ Pre (n = 18) |
H-FZ Post (n = 18) |
p | n.v. (% rel.) |
---|---|---|---|---|---|---|---|---|---|---|
C20:4n6 AA) | 17.42 ± 0.76 | 16.60 ± 0.69 | ns | 17.01 ± 1.32 | 15.92 ± 1.06 | ns | 17.88 ± 0.71 | 17.37 ± 0.84 | ns | 13–17 |
C20:5n3 (EPA) | 0.80 ± 0.08 | 0.91 ± 0.08 | ns | 0.92 ± 0.12 | 1.04 ± 0.14 | ns | 0.68 ± 0.09 | 0.76 ± 0.07 | ns | 0.5–0.9 |
n-6 PUFAs | 28.45 ± 0.79 | 26.64 ± 0.64 | 0.010 | 28.25 ± 1.25 | 26.75 ± 0.85 | ns | 28.67 ± 0.99 | 26.53 ± 0.99 | 0.025 | 24–34 |
n-3 PUFAs | 8.35 ± 0.55 | 8.52 ± 0.48 | ns | 9.74 ± 0.81 * | 8.89 ± 0.81 | ns | 6.81 ± 0.57 * | 8.12 ± 0.51 | 0.043 | 5.7–9 |
Total PUFAs | 36.86 ± 1.05 | 35.59 ± 0.85 | ns | 37.47 ± 1.64 | 35.45 ± 1.32 | ns | 36.19 ± 1.30 | 35.76 ± 1.08 | ns | 28–39 |
AA/EPA ratio | 28.50 ± 3.16 | 23.82 ± 2.55 | ns | 21.26 ± 2.21 *** | 20.59 ± 3.07 | ns | 36.54 ± 5.72 *** | 27.42 ± 4.11 | 0.048 | <15 |
n-6/n-3 PUFAs ratio | 4.17 ± 0.55 | 3.54 ± 0.22 | ns | 3.15 ± 0.22 ** | 3.51 ± 0.33 | ns | 5.31 ± 1.10 ** | 3.56 ± 0.29 | 0.002 | 3–4.5 |
LFD = low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet; AA = arachidonic acid; EPA = eicosapentaenoic acid; PUFAs = polyunsaturated fatty acids. Data are presented as the means ± SEM. The Wilcoxon rank-sum test was used to determine the p-value for comparisons of pre- and post-treatment data. The Mann–Whitney test compared the two subgroups before and after the diet. Statistical significance was set at p < 0.05. ns = not significant. n.v.: normal values. * N-FZ pre vs. H-FZ pre, p = 0.008; ** N-FZ pre vs. H-FZ pre, p = 0.006; *** N-FZ pre vs. H-FZ pre, p = 0.030. At the end of this study, no significant differences in PUFAs levels were found between the H-FZ and N-FZ subgroups.